A Case of Palmoplantar Pustulosis Induced by Certolizumab Pegol: New Anti-TNF-alpha Demonstrates the Same Class Effect.

scientific article published on August 2012

A Case of Palmoplantar Pustulosis Induced by Certolizumab Pegol: New Anti-TNF-alpha Demonstrates the Same Class Effect. is …
instance of (P31):
scholarly articleQ13442814

External links are
P932PMC publication ID3424592
P698PubMed publication ID22916313

P2093author name stringMaria Miteva
Francisco A Kerdel
Magalys Vitiello
Michael L Shelling
Paolo Romanelli
Emma L Lanuti
P2860cites workRates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.Q37020532
Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patientsQ37037622
Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD studyQ37172815
Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical reviewQ37560336
Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesisQ37767889
Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case seriesQ79169980
P433issue8
P921main subjectTNF inhibitorQ1536078
generalized pustular psoriasisQ5532501
pustulosisQ7262033
P304page(s)40-41
P577publication date2012-08-01
P1433published inThe Journal of clinical and aesthetic dermatologyQ26842086
P1476titleA Case of Palmoplantar Pustulosis Induced by Certolizumab Pegol: New Anti-TNF-alpha Demonstrates the Same Class Effect
P478volume5

Reverse relations

Q36904729Paradoxes in dermatologycites workP2860

Search more.